Use of ketamine for depression and suicidality in cancer and terminal patients: Review of current data
AIMS Public Health 2023 Aderonke Oyetunji, C. Blanco Huelga, Kailee Bunte et al. 9 citations
Depression and suicidality are significant challenges faced by cancer patients, particularly those in advanced stages of the disease or nearing the end of life. Conventional antidepressant therapies often have limited effectiveness or delayed onset of action, making the exploration of alternative treatments crucial. The use of ketamine as a potential treatment for depression and suicidality in...